This chapter is reprinted and available individually from Good Distribution Practice: A Handbook for Healthcare Manufacturers and Suppliers, Volume 1 edited by Siegfried Schmitt, a text that collects in one place invaluable and comprehensive regulatory, manufacturing and distribution guidance and reference.
"The only way to be able to protect patients from substandard and falsified medical products is that each and every part of the manufacturing and supply chain is aware of its own influence on the quality of a medicinal product ... by preventing any negative influence of the quality, efficacy or safety ... and
assuring that the medicinal product stays within the legal supply chain."
From the text Foreword by Lea Joos, Government of Upper Bavaria
Get current by reading this reprint and the additional 25 other timely and informative chapters to be found in Good Distribution Practice: A Handbook for Healthcare Manufacturers and Suppliers, Volumes 1 and 2, edited by Siegfried Schmitt. Description details, a complete Table of Contents and details about purchase of the two volume set will be found at: go.pda.org/GDP1 and go.pda.org/GDP2
Available to download. Prior to purchase please view the download instructions and Terms of Usage
Format: PDF (1 file 1.10 MB)
About the Author
Alan Kennedy is a specialist in supply chain dynamics who, with his extensive cross-sector experience, is focused on bringing best-collaboration practice to pharma-logistics. He is the founder and Executive Director of Pharma TEAM-UP, a non-profit initiative with the goal of fostering closer supply chain integration and he is one of the principal architects behind the Poseidon program, a new logistics delivery model that has been conceived to radically transform the transportation of pharmaceutical products by sea. This is being achieved through the application of contemporary supply chain best-practice and structured, multi-party collaboration. He regularly presents on this topic and has authored numerous papers.